Functional diversity of human vaginal APC subsets in directing T-cell responses

Mucosal Immunology

Volumn 6, Issue 3, 2013, Pages 626-638

  Duluc, D ^a   Gannevat, J ^a   Anguiano, E ^a   Zurawski, S ^a   Carley, M ^b   Boreham, M ^b   Stecher, J ^b   Dullaers, M ^a   Banchereau, J ^c   Oh, S ^a,d  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d INSERM U955   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PATTERN RECOGNITION RECEPTOR;

ADULT; AGED; ANTIGEN PRESENTING CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL STRUCTURE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LAMINA PROPRIA; LANGERHANS CELL; MACROPHAGE; MICROARRAY ANALYSIS; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VAGINA; VAGINA MUCOSA;

EID: 84876391624     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.104     Document Type: Article

References (50)

1. Mestecky, J., Moldoveanu, Z., Smith, P.D., Hel, Z. & Alexander, R.C. Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection. J. Reprod. Immunol. 83, 196-200 (2009).
2. Iwasaki, A. Antiviral immune responses in the genital tract: clues for vaccines. Nat. Rev. Immunol. 10, 699-711 (2010).
3. Mestecky, J., Moldoveanu, Z. & Russell, M.W. Immunologic uniqueness of the genital tract: challenge for vaccine development. Am. J. Reprod. Immunol. 53, 208-214 (2005).
4. Russell, M.W. & Mestecky, J. Tolerance and protection against infection in the genital tract. Immunol. Invest. 39, 500-525 (2010).
5. Russell, M.W. & Mestecky, J. Humoral immune responses to microbial infections in the genital tract. Microbes Infect. 4, 667-677 (2002).
6. Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003).
7. Villadangos, J.A. & Schnorrer, P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7, 543-555 (2007).
8. Pulendran, B., Palucka, K. & Banchereau, J. Sensing pathogens and tuning immune responses. Science 293, 253-256 (2001).
9. Iijima, N., Thompson, J.M. & Iwasaki, A. Dendritic cellsand macrophagesin the genitourinary tract. Mucosal Immunol. 1, 451-459 (2008).
10. Parr, M.B., Kepple, L. & Parr, E.L. Langerhans cells phagocytose vaginal epithelial cells undergoing apoptosis during the murine estrous cycle. Biol. Reprod. 45, 252-260 (1991).
11. Iijima, N. et al. Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J. Exp. Med. 205, 3041-3052 (2008).
12. Jameson, B. et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J. Virol. 76, 1866-1875 (2002).
13. Hussain, L.A. et al. Expression and gene transcript of Fc receptors for IgG, HLA class II antigens and Langerhans cells in human cervico-vaginal epithelium. Clin. Exp. Immunol. 90, 530-538 (1992).
14. Hershberg, R.M. et al. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J. Clin. Invest. 100, 204-215 (1997).
15. Taflin, C. et al. Human endothelial cells generate Th17 and regulatory Tcells under inflammatory conditions. Proc. Natl. Acad. Sci. USA 108, 2891-2896 (2011).
16. Blauvelt, A., Katz, S.I. & Udey, M.C. Human Langerhans cells express E-cadherin. J. Invest. Dermatol. 104, 293-296 (1995).
17. Zaba, L.C., Fuentes-Duculan, J., Steinman, R.M., Krueger, J.G. & Lowes, M.A. Normal human dermis contains distinct populations of CD11c +BDCA-1 + dendritic cells and CD163 +FXIIIA + macrophages. J. Clin. Invest. 117, 2517-2525 (2007).
18. Serbina, N.V., Jia, T., Hohl, T.M. & Pamer, E.G. Monocyte-mediated defense against microbial pathogens. Annu. Rev. Immunol. 26, 421-452 (2008).
19. Hladik, F. et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26, 257-270 (2007).
20. Williams, I.R. Chemokine receptors and leukocyte trafficking in the mucosal immune system. Immunol. Res. 29, 283-292 (2004).
21. van de Veerdonk, F.L. et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365, 54-61 (2011).
22. Puel, A. et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332, 65-68 (2011).
23. Ferwerda, B. et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N. Engl. J. Med. 361, 1760-1767 (2009).
24. Mathers, A.R. et al. Differential capability of human cutaneous dendritic cell subsets to initiate Th17 responses. J. Immunol. 182, 921-933 (2009).
25. Klechevsky, E. et al. Functional Specializations of Human Epidermal Langerhans Cells and CD14(+) Dermal Dendritic Cells. Immunity 29, 497-510 (2008).
26. Hladik, F., Lentz, G., Delpit, E., McElroy, A. & McElrath, M.J. Coexpression of CCR5 and IL-2 in human genital but not blood Tcells: implications for the ontogeny of the CCR5 + Th1 phenotype. J. Immunol. 163, 2306-2313 (1999).
27. Stevceva, L. et al. Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importanceincytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251. J. Virol. 76, 9-18 (2002).
28. Schon, M.P. et al. Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J. Immunol. 162, 6641-6649 (1999).
29. Csencsits, K.L., Walters, N. & Pascual, D.W. Cutting edge: dichotomy of homing receptor dependence by mucosal effector B cells: alpha(E) vs. L-selectin. J. Immunol. 167, 2441-2445 (2001).
30. Nakanishi, Y., Lu, B., Gerard, C. & Iwasaki, A. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462, 510-513 (2009).
31. Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105 (2006).
32. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
33. Wagner, T.L. et al. ModulationofTH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol. 191, 10-19 (1999).
34. Kolls, J.K., McCray, P.B. Jr. & Chan, Y.R. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 8, 829-835 (2008).
35. Ouyang, W. & Valdez, P. IL-22 in mucosal immunity. Mucosal Immunol. 1, 335-338 (2008).
36. Malmberg, K.J. & Ljunggren, H.G. Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. Nat. Immunol. 10, 11-12 (2009).
37. Vivier, E., Spits, H. & Cupedo, T. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?. Nat. Rev. Immunol. 9, 229-234 (2009).
38. Fujita, H., Nograles, K.E., Kikuchi, T., Gonzalez, J., Carucci, J.A. & Krueger, J.G. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc. Natl. Acad. Sci. USA 106, 21795-21800 (2009).
39. Furio, L, Briotet, I., Journeaux, A., Billard, H. & Peguet-Navarro, J. Human langerhans cells are more efficient than CD14(-)CD1c(+) dermal dendritic cells at priming naive CD4(+) T cells. J. Invest. Dermatol. 130, 1345-1354 (2010).
40. Rimoldi, M. et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6, 507-514 (2005).
41. Parr, E.L. & Parr, M.B. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. Immunology 98, 639-645 (1999).
42. Gillgrass, A.E., Tang, VA, Towarnicki, K.M., Rosenthal, K.L. & Kaushic, C. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue. J. Virol. 79, 3117-3126 (2005).
43. Wu, H.Y., Abdu, S., Stinson, D. & Russell, M.W. Generation of female genital tract antibody responses by local or central (common) mucosal immunization. Infect. Immun. 68, 5539-5545 (2000).
44. Ogra, PL & Ogra, S.S. Local antibody response to polio-vaccine in the human female genital tract. J. Immunol. 110, 1307-1311 (1973).
45. Kozlowski, P.A. et al. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J. Immunol. 169, 566-574 (2002).
46. Kozlowski, P.A., Cu-Uvin, S., Neutra, M.R. & Flanigan, T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65, 1387-1394 (1997).
47. Nelson, M.H. et al. Rapid clearance of herpes simplex virus type 2 by CD8 + T cells requires high level expression of effector T cell functions. J. Reprod. Immunol. 89, 10-17 (2011).
48. Kaushic, C, Zhou, F., Murdin, A.D. & Wira, CR. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 68, 4207-4216 (2000).
49. Prieto, G.A. & Rosenstein, Y. Oestradiol potentiates the suppressive function of human CD4 CD25 regulatory T cells by promoting their proliferation. Immunology 118, 58-65 (2006).
50. Wira, C.R., Roche, M.A. & Rossoll, R.M. Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation. Endocrinology 143, 2872-2879 (2002).